Answer all the questions in sequence , according to a final year MBBS student in India . Refer latest edition of Ghai Essential Pesiatrics book . Refer page number given on top corners to maintain the sequence ( don't break the sequence ) There are also topics given on the top of every set of questions ( Answer topic wise and don't break the sequence ) Answer should be in points , use flow charts (make it properly) and diagrams to explain the concept properly.
You are helping answer MBBS Final Year Pediatrics questions from Ghai Essential Pediatrics (10th edition) for an Indian medical student. Use the medical library database (query_library_db) to find relevant content. Search for each topic using headings_fts and paragraphs_fts. Read the actual file content using read_file with the paths returned. Cover these topics IN SEQUENCE: **TOPIC 1: INTRODUCTION TO PEDIATRICS (Pages 170-171)** Q1. Define infant mortality rate and its causes. Discuss strategies to reduce IMR. (Ref: 10th ed, p.2) Q2. Discuss medico-legal, socio-cultural, professional and ethical issues pertaining to malpractice. (Ref: 10th ed, p.4) Q3. Describe key strategies and beneficiaries under JSSK. (Ref: 10th ed, p.4) Q4. Describe key strategies and beneficiaries under RBSK. (Ref: 10th ed, p.4) Q5. Causes of under-five mortalities in developing world (Ref: 10th ed, p.4) Q6. IMNCI Program of Government of India (Ref: 10th ed, p.3) **TOPIC 2: GROWTH AND DEVELOPMENT (Pages 170-171)** Q1. Discuss developmental milestones achieved by 3 years of age (Ref: 10th ed, p.24) Q2. List key developmental milestones achieved by a normal child at 2 years under various domains (Ref: 10th ed, p.24) Q3. Define short stature. Write about d/d, investigations and management. (Ref: 10th ed, p.24) Q4. Differentiate between growth and development. Discuss factors affecting growth and development in children. (Ref: 10th ed, p.16) Q5. Describe age-independent anthropometric measurement and management of child with SAM. (Ref: 10th ed, p.6) Q6. Growth and development in 1st year of life. (Ref: 10th ed, p.24) Q7. Weight, height, and head circumference of 4-year-old child (Ref: 10th ed, p.24) - Weight, height, head circumference, chest circumference of 1-year-old child (Ref: 10th ed, p.12) Q8. Factors affecting growth and methods of growth monitoring (Ref: 10th ed, p.8) Q9. Make a table of age of achievement of key milestones in first year of life in gross motor, fine motor, personal social and language domains (Ref: 10th ed, p.24) Q10. Briefly describe sexual maturity rating or Tanner Staging (Ref: 10th ed, p.48) **TOPIC 3: DEVELOPMENTAL AND BEHAVIORAL DISORDERS (Page 172)** Q1. Short note on attention deficit disorders. (Ref: 10th ed, p.44) Q2. Physical and behavioral problems in adolescents and their management. (Ref: 10th ed, p.50) Q3. Discuss common behavioral problems in children and treatment of breath-holding spell. (Ref: 10th ed, p.46) Q4. Breath-holding spells (Ref: 10th ed, p.46) Q5. Definition, clinical features and diagnosis of delayed puberty in a girl child. (Ref: 10th ed, p.557) **TOPIC 4: FLUID AND ELECTROLYTE IMBALANCE (Page 172)** Q1. Syndrome of inappropriate ADH secretion (SIADH) (Ref: 10th ed, p.72) Q2. Hypokalemia (Ref: 10th ed, p.63) Q3. Hyperkalemia (Ref: 10th ed, p.64) Q4. Hyponatremia Q5. Hypernatremia (Ref: 10th ed, p.59) - Management of a 1-year-old child with serum sodium 115 mEq/L (Ref: 10th ed, p.59) For each question, provide: - Definition (if applicable) - Etiology/Causes (as bullet points) - Pathophysiology (brief) - Clinical features (bullet points) - Investigations - Management (flowchart style where applicable) - Key facts/mnemonics Use query_library_db first to find the relevant sections, then read_file to get actual content. Return detailed, well-structured answers with flowcharts using ASCII/text format.
You are helping answer MBBS Final Year Pediatrics questions from Ghai Essential Pediatrics (10th edition) for an Indian medical student. Use the medical library database (query_library_db) and read_file to find relevant content on each topic, then write comprehensive answers. Cover these topics IN SEQUENCE: **TOPIC 5: NUTRITION AND RELATED DISEASES (Pages 172-174)** Q1. SAM (Severe Acute Malnutrition) - definition, classification, clinical features, WHO 10-step management Q2. Management of case of malnutrition (PEM) (Ref: 10th ed, p.88) Q3. WHO classification of PEM and management of severe wasting (Ref: 10th ed, p.87) Q4. Complications of severe malnutrition Q5. Nutritional management of a severely wasted 1-year-old child weighing 5 kg Q6. Discuss the steps in synthesis of vitamin D. Write clinical features, investigation and treatment of rickets (Ref: 10th ed, p.102) Q7. Discuss radiological findings in scurvy (Ref: 10th ed, p.114) Q8. Classification of PEM and management of severe malnutrition (Ref: 10th ed, p.87) Q9. Principles of management of PEM (Ref: 10th ed, p.91) Q10. Pseudoparalysis (Ref: 10th ed, p.114) Q11. Refractory rickets (Ref: 10th ed, p.107) Q12. Complementary feeding (Ref: 10th ed, p.82) Q13. Clinical signs and treatment of vitamin A deficiency (Ref: 10th ed, p.101) **TOPIC 6: NEONATOLOGY (Pages 174-177)** Q1. Exclusive breastfeeding (Ref: 10th ed, p.142) Q2. Algorithm for neonatal resuscitation (Ref: 10th ed, p.122) Q3. Neonatal jaundice causes and treatment (Ref: 10th ed, p.170) Q4. Management of neonatal jaundice and clinical features of brain damage from increased bilirubin (Ref: 10th ed, p.170) Q5. Differential diagnosis of cyanosis of the newborn (Ref: 10th ed, p.161) Q6. Role of Apgar score in neonatal resuscitation (Ref: 10th ed, p.121) Q7. Advantages of breastfeeding (Ref: 10th ed, p.142) Q8. Handicaps of LBW baby (Ref: 10th ed, p.148) Q9. Tracheoesophageal fistula (Ref: 10th ed, p.175) Q10. Resuscitation of meconium-stained baby at birth (Ref: 10th ed, p.160) Q11. Causes, clinical features and management of perinatal asphyxia (Ref: 10th ed, p.161) Q12. Feeding of LBW neonates (Ref: 10th ed, p.152) Q13. Management of LBW neonates (Ref: 10th ed, p.148) Q14. Etiology, causes, pathogenesis, clinical features, treatment and management of RDS (respiratory distress syndrome) in neonates (Ref: 10th ed, p.156) Q15. Physical features of term neonate, Classify by weight, describe gestation and routine newborn care (Ref: 10th ed, p.127) Q16. Phototherapy (mechanism of action, indication and complication) (Ref: 10th ed, p.174) Q17. Neonatal sepsis (Ref: 10th ed, p.166) Q18. Antenatal corticosteroids in preterm labor - drug, dosing, indications, contraindications, benefits (Ref: 10th ed, p.158) Q19. Temperature regulation in neonates and management of hypothermia (Ref: 10th ed, p.139) Q20. Danger signs in a neonate (Ref: 10th ed, p.156) Q21. Lactation failure (Ref: 10th ed, p.146) Q22. ARDS (Ref: 10th ed, p.157) Q23. Hyaline membrane disease (Ref: 10th ed, p.157) **TOPIC 7: IMMUNIZATION (Pages 176-178)** Q1. Never vaccines (newer vaccines) (Ref: 10th ed, p.201) Q2. Pneumococcal vaccine (Ref: 10th ed, p.199) Q3. National Rural Health Mission (NRHM) (Ref: 10th ed, p.189) Q4. Optional vaccines (Ref: 10th ed, p.199) Q5. IPV (Ref: 10th ed, p.193) Q6. Complications of BCG and DPT vaccines (Ref: 10th ed, p.190) Q7. Adverse events following immunization (AEFI) (Ref: 10th ed, p.212) Q8. Conjugate vaccines (Ref: 10th ed, p.199) Q9. Mission Indradhanush (Ref: 10th ed, p.191) Q10. Universal Immunization Program (Ref: 10th ed, p.189) Q11. Vaccination at 6 weeks (Ref: 10th ed, p.190) Q12. Baby received routine vaccination at 6 weeks - side effects advice (Ref: 10th ed, p.190) Q13. MMR vaccine (Ref: 10th ed, p.197) Q14. MR vaccine (Ref: 10th ed, p.197) **TOPIC 8: COMMON INFECTIONS (Pages 178-180)** Q1. Transmission and prevention of parent-to-child transmission of HIV (Ref: 10th ed, p.251) Q2. Diagnosis and treatment of malaria (Ref: 10th ed, p.275) Q3. Complications of diphtheria (Ref: 10th ed, p.275) Q4. Management of dengue shock syndrome (Ref: 10th ed, p.264) Q5. Transmission and control of dengue fever (Ref: 10th ed, p.241) Q6. Post-exposure prophylaxis of HIV infection (Ref: 10th ed, p.250) Q7. Tuberculin test/Mantoux test (Ref: 10th ed, p.246) Q8. Primary complex TB (Ref: 10th ed, p.258) Q9. Diagnosis of TB in children (Ref: 10th ed, p.256) Q10. Currently recommended regimen and drug dosages for pediatric TB (Ref: 10th ed, p.259) Q11. Clinical features and complications of measles (Ref: 10th ed, p.230) Q12. Enteric fever (Ref: 10th ed, p.266) Q13. Why Campylobacter jejuni causes disease beyond bloody diarrhea (Ref: 10th ed, p.309) Q14. Explain why antibiotics need not be given in all cases of blood-mixed stools (Ref: 10th ed, p.309) **TOPIC 9: GIT DISORDERS (Pages 180-181)** Q1. Celiac disease - clinical features and management (Ref: 10th ed, p.318) Q2. Discuss causes, clinical picture and management of hepatic encephalopathy (Ref: 10th ed, p.318) Q3. Persistent diarrhea in children (Ref: 10th ed, p.317) Q4. Persistent and chronic diarrhea - clinical features and management (Ref: 10th ed, p.317) Q5. Management of child with some severe dehydration (Ref: 10th ed, p.312) Q6. Plan B for management of diarrhea with dehydration (Ref: 10th ed, p.312) Q7. Management of 1-year-old weighing 9 kg presenting with dysentery (Ref: 10th ed, p.312) Q8. Management of 1-year-old weighing 6 kg with acute diarrhea and some dehydration (Ref: 10th ed, p.312) Q9. Etiology and management of chronic diarrhea in 5-year-old child (Ref: 10th ed, p.312) Q10. 1-year-old infant weighing 5.5 kg with acute dysentery and severe dehydration (Ref: 10th ed, p.317) Q11. Management of child with recurrent abdominal pain (Ref: 10th ed, p.303) Q12. Low osmolar ORS (Ref: 10th ed, p.289) Q13. Plan C treatment (Ref: 10th ed, p.312) Q14. Causes and management of hematemesis (Ref: 10th ed, p.325) Q15. Evaluation of an infant with cholestasis (Ref: 10th ed, p.345) For each question, provide: - Definition (if applicable) - Etiology/Causes (as bullet points) - Pathophysiology (brief) - Clinical features (bullet points) - Investigations - Management (flowchart style where applicable) - Key facts/mnemonics Use query_library_db first to find the relevant sections using headings_fts and paragraphs_fts, then read_file to get actual content from the Ghai Pediatrics book. Return detailed, well-structured answers with ASCII flowcharts where applicable.
Are we working on the WORD document?
Create a PDF version as well for easy sharing
ls -la /tmp/workspace/ 2>/dev/null || mkdir -p /tmp/workspace && echo "workspace ready"
mkdir -p /tmp/workspace/pediatrics-answerbook && echo "Directory created"
Where's the pdf ?
?
?
?
mkdir -p /tmp/workspace/pediatrics-answerbook && python3 << 'PYEOF' from docx import Document from docx.shared import Pt, Inches, RGBColor from docx.enum.text import WD_ALIGN_PARAGRAPH from docx.oxml.ns import qn from docx.oxml import OxmlElement doc = Document() # ── Page margins ────────────────────────────────────────────────────────────── for section in doc.sections: section.top_margin = Inches(1) section.bottom_margin = Inches(1) section.left_margin = Inches(1.2) section.right_margin = Inches(1.2) # ── Default body style ──────────────────────────────────────────────────────── normal = doc.styles["Normal"] normal.font.name = "Arial" normal.font.size = Pt(11) # ── Helper functions ────────────────────────────────────────────────────────── def h1(text): p = doc.add_heading(text, level=1) p.runs[0].font.color.rgb = RGBColor(0x1F, 0x49, 0x7D) return p def h2(text): p = doc.add_heading(text, level=2) p.runs[0].font.color.rgb = RGBColor(0x2E, 0x74, 0xB5) return p def h3(text): p = doc.add_heading(text, level=3) p.runs[0].font.color.rgb = RGBColor(0x00, 0x70, 0xC0) return p def body(text): doc.add_paragraph(text) def bullet(text, level=0): doc.add_paragraph(text, style="List Bullet") def numbered(text): doc.add_paragraph(text, style="List Number") def add_table(headers, rows): t = doc.add_table(rows=1 + len(rows), cols=len(headers)) t.style = "Light List Accent 1" hrow = t.rows[0].cells for i, h in enumerate(headers): hrow[i].text = h for run in hrow[i].paragraphs[0].runs: run.bold = True for ri, row in enumerate(rows): cells = t.rows[ri+1].cells for ci, val in enumerate(row): cells[ci].text = val doc.add_paragraph() def box(text): """Monospace block for flowcharts.""" p = doc.add_paragraph() p.style = doc.styles["No Spacing"] run = p.add_run(text) run.font.name = "Courier New" run.font.size = Pt(9) doc.add_paragraph() def pagebreak(): doc.add_page_break() # ══════════════════════════════════════════════════════════════════════════════ # COVER PAGE # ══════════════════════════════════════════════════════════════════════════════ title_para = doc.add_paragraph() title_para.alignment = WD_ALIGN_PARAGRAPH.CENTER run = title_para.add_run("MBBS FINAL YEAR — PEDIATRICS\nUNSOLVED QUESTIONS: COMPLETE ANSWER BOOK") run.bold = True run.font.size = Pt(20) run.font.color.rgb = RGBColor(0x1F, 0x49, 0x7D) doc.add_paragraph() sub = doc.add_paragraph() sub.alignment = WD_ALIGN_PARAGRAPH.CENTER r2 = sub.add_run("Reference: Ghai Essential Pediatrics, 10th Edition\nVinod K Paul & Arvind Bagga\nPrepared for MBBS Final Prof (Part-II) Examination — India") r2.font.size = Pt(13) r2.font.color.rgb = RGBColor(0x2E, 0x74, 0xB5) doc.add_paragraph() note = doc.add_paragraph() note.alignment = WD_ALIGN_PARAGRAPH.CENTER nr = note.add_run("Answers in Points • Flowcharts • Tables • Diagrams\nSequenced as per Page Numbers 170–189") nr.italic = True nr.font.size = Pt(11) pagebreak() # ══════════════════════════════════════════════════════════════════════════════ # TOPIC 1 — INTRODUCTION TO PEDIATRICS (pp. 170-171) # ══════════════════════════════════════════════════════════════════════════════ h1("TOPIC 1: INTRODUCTION TO PEDIATRICS") body("Reference: Ghai Essential Pediatrics, 10th ed., pp. 2–4") doc.add_paragraph() h2("Q1. Define Infant Mortality Rate (IMR). Discuss its causes and strategies to reduce IMR.") h3("Definition") body("Infant Mortality Rate (IMR) = Number of deaths of infants (<1 year) per 1000 live births in the same year.") box( " Deaths in children < 1 year of age\n" "IMR = ──────────────────────────────────────── × 1000\n" " Total live births in same year" ) h3("Components of IMR") add_table( ["Component","Age Group","Main Causes"], [ ["Neonatal Mortality Rate (NMR)","0–28 days","Prematurity, birth asphyxia, sepsis, congenital anomalies"], ["Post-neonatal Mortality Rate","29 days–1 year","ARI (pneumonia), diarrhea, malnutrition, vaccine-preventable diseases"], ] ) h3("Causes of Infant Mortality") bullet("Prematurity / Low Birth Weight (LBW)") bullet("Birth asphyxia and birth trauma") bullet("Neonatal sepsis") bullet("Respiratory Distress Syndrome (RDS)") bullet("Congenital anomalies") bullet("Acute Respiratory Infections (ARI) — Pneumonia (post-neonatal)") bullet("Diarrheal diseases and dehydration (post-neonatal)") bullet("Malnutrition") bullet("Vaccine-preventable diseases — measles, pertussis") bullet("Hypothermia and hypoglycemia") h3("India IMR Key Data") add_table( ["Year","IMR (per 1000 live births)"], [["1970","129"],["1990","80"],["2010","47"],["2018","32"],["Target (SDG)","<12 by 2030"]] ) h3("Strategies to Reduce IMR") box( "┌──────────────────────────────────────────────────────────────┐\n" "│ STRATEGIES TO REDUCE IMR │\n" "├─────────────────┬────────────────────────────────────────────┤\n" "│ ANTENATAL │ Focused ANC (min 4 visits) │\n" "│ │ Iron-folic acid supplementation │\n" "│ │ TT immunization, detect high-risk preg. │\n" "├─────────────────┼────────────────────────────────────────────┤\n" "│ INTRANATAL │ Skilled attendance at birth │\n" "│ │ Institutional delivery │\n" "│ │ Emergency obstetric care (EmOC) │\n" "│ │ Clean delivery practices │\n" "├─────────────────┼────────────────────────────────────────────┤\n" "│ POSTNATAL │ Essential newborn care (warmth, cord care) │\n" "│ │ Exclusive breastfeeding × 6 months │\n" "│ │ Universal Immunization Program (UIP) │\n" "│ │ IMNCI / F-IMNCI │\n" "├─────────────────┼────────────────────────────────────────────┤\n" "│ GOVT PROGRAMS │ JSSK, RBSK, NHM, Poshan Abhiyan │\n" "│ │ Anaemia Mukt Bharat, Pradhan Mantri Surakshit │\n" "├─────────────────┼────────────────────────────────────────────┤\n" "│ SOCIAL │ Female education, family planning │\n" "│ │ Poverty alleviation, improved sanitation │\n" "└─────────────────┴────────────────────────────────────────────┘" ) h2("Q2. Medico-legal, Socio-cultural, Professional and Ethical Issues in Malpractice") h3("Medico-legal Issues") bullet("Civil negligence: Failure to exercise reasonable care → compensation") bullet("Criminal negligence: Gross negligence with reckless disregard → prosecution") bullet("Informed consent: Must be from parent/guardian for minors; assent from child when possible") bullet("Medical records: Must be accurate, complete, legible — they are legal documents") bullet("Res ipsa loquitur — 'the thing speaks for itself'") bullet("Vicarious liability — institution responsible for acts of its staff") h3("Socio-cultural Issues") bullet("Traditional beliefs — giving water/honey to newborns, delaying breastfeeding") bullet("Gender discrimination — neglect of female infants") bullet("Faith healing — refusing evidence-based treatment") bullet("Vaccine hesitancy due to myths and religious beliefs") bullet("Food taboos causing malnutrition") bullet("Consanguineous marriages increasing genetic disorders") h3("Ethical Issues — Four Principles (Beauchamp & Childress)") add_table( ["Principle","Application in Pediatrics"], [ ["Autonomy","Parental autonomy vs. child's best interest"], ["Beneficence","Act in child's best interest at all times"], ["Non-maleficence","Avoid unnecessary harm, invasive procedures"], ["Justice","Equal access to care regardless of gender/SES"], ] ) h3("Special Pediatric Ethical Dilemmas") bullet("Withdrawing treatment in critically ill neonates") bullet("Refusal of blood transfusion by Jehovah's Witnesses") bullet("Child abuse — mandatory reporting vs. confidentiality") bullet("Sex determination — prohibited under PCPNDT Act, 1994") h2("Q3. JSSK — Janani Shishu Suraksha Karyakram") body("Launched: 1st June 2011 | Objective: Zero out-of-pocket expenditure for pregnant women and sick newborns") h3("Entitlements for Pregnant Women") bullet("Free delivery (including Caesarean section)") bullet("Free drugs and consumables") bullet("Free diet: 3 days (normal delivery); 7 days (C-section)") bullet("Free diagnostics") bullet("Free blood transfusion where required") bullet("Free transport: home → institution → referral → home") h3("Entitlements for Sick Newborns (up to 30 days)") bullet("Free treatment, drugs, diagnostics, diet, blood, transport") h2("Q4. RBSK — Rashtriya Bal Swasthya Karyakram") body("Launched: February 2013 | Objective: Child Health Screening and Early Intervention (0–18 years)") h3("4 Ds of RBSK") box( "┌──────┬───────────────────────────────────────────┐\n" "│ D1 │ Defects at Birth │\n" "│ D2 │ Diseases in Children │\n" "│ D3 │ Deficiency Conditions │\n" "│ D4 │ Developmental Delays & Disabilities │\n" "└──────┴───────────────────────────────────────────┘" ) h3("30 Identified Conditions (Key Examples)") bullet("Defects at Birth (9): Neural tube defect, Down syndrome, Cleft lip/palate, Talipes, DDH, Congenital cataract, Congenital deafness, CHD, ROP") bullet("Deficiency Conditions (5): Severe anaemia, Vit A deficiency, Vit D deficiency (rickets), SAM, Goitre") bullet("Childhood Diseases (6): Scabies/skin, Otitis media, RHD, Asthma, Dental caries, Convulsive disorders") bullet("Developmental Delays (10): Vision, hearing, neuro-motor, motor, cognitive, language, autism, learning disorder, ADHD, congenital hypothyroidism") h2("Q5. Causes of Under-Five Mortality in Developing World") add_table( ["Cause","Approx. %","Key Pathogens/Notes"], [ ["Neonatal causes","~40%","Preterm, birth asphyxia, neonatal sepsis"], ["Pneumonia (ARI)","~16%","Strep. pneumoniae, H. influenzae"], ["Diarrheal diseases","~9%","Rotavirus, E. coli; dehydration kills"], ["Malaria","~7%","Sub-Saharan Africa predominantly"], ["Malnutrition (associated)","~45% of all deaths","Underlying factor"], ["Measles","~2–3%","Declining with vaccination"], ["Injuries","~5%","Drowning, burns, road traffic"], ] ) h2("Q6. IMNCI — Integrated Management of Neonatal and Childhood Illness") body("India-specific adaptation of WHO's IMCI; unique: includes first 7 days of life (neonatal period)") h3("Three Components") bullet("1. Improving health worker skills through training in evidence-based case management") bullet("2. Health system improvements: drug availability, referral, equipment") bullet("3. Family and community practices: when to seek care, home management, nutrition counselling") h3("IMNCI Case Management Process (Flowchart)") box( "STEP 1: ASSESS the child\n" " ↓\n" " Check DANGER SIGNS + Common conditions + Nutrition/Immunization\n" " ↓\n" "STEP 2: CLASSIFY using Colour-Coded System\n" " ┌─────────────┐ ┌─────────────┐ ┌─────────────┐\n" " │ PINK │ │ YELLOW │ │ GREEN │\n" " │ Urgent │ │ Specific │ │ Home │\n" " │ Referral │ │ Treatment │ │ Management │\n" " └─────────────┘ └─────────────┘ └─────────────┘\n" " ↓\n" "STEP 3: TREAT — pre-referral Rx (pink); first dose drugs (yellow)\n" " ↓\n" "STEP 4: COUNSEL parent — feeding, home care, follow-up\n" " ↓\n" "STEP 5: FOLLOW-UP — reassess on return visit" ) pagebreak() # ══════════════════════════════════════════════════════════════════════════════ # TOPIC 2 — GROWTH AND DEVELOPMENT (pp. 170-171) # ══════════════════════════════════════════════════════════════════════════════ h1("TOPIC 2: GROWTH AND DEVELOPMENT") body("Reference: Ghai Essential Pediatrics, 10th ed., pp. 8–48") doc.add_paragraph() h2("Q1 & Q2. Developmental Milestones at 2 Years and 3 Years of Age") add_table( ["Domain","2 Years (24 months)","3 Years (36 months)"], [ ["Gross Motor","Runs; kicks ball; walks up stairs with help","Rides tricycle; walks up stairs (alternate feet); broad jump"], ["Fine Motor","Stacks 5–6 cubes; turns book pages one at a time","Draws circle (when shown); strings beads; puts on loose clothes"], ["Language","50+ words; 2-word phrases ('more milk'); points to body parts","250+ words; 3-word sentences; asks who/what/where; own name"], ["Personal-Social","Parallel play; toilet training begins","Group play; calms within 10 min of separation"], ["Cognitive","Uses toy correctly; holds + removes lid","Avoids hot objects when warned; draws circle"], ] ) h2("Q3. Short Stature — Definition, D/D, Investigations, Management") h3("Definition") bullet("Short stature: Height < 2 SD below mean (< 3rd percentile) for age and sex") bullet("Growth failure: Height < 2 SD below mid-parental height OR height velocity < 10th percentile") h3("Differential Diagnosis (Flowchart)") box( " SHORT STATURE\n" " │\n" " ┌──────────────┼──────────────────┐\n" " ▼ ▼ ▼\n" " FAMILIAL SS CONSTITUTIONAL PATHOLOGICAL\n" " ───────── GROWTH DELAY CAUSES\n" " Normal GV Normal GV Low GV\n" " Normal BA Delayed BA BA varies\n" " Family Hx: Family Hx: Depends on\n" " short stature delayed puberty underlying\n" " Final Ht: SHORT Final Ht: NORMAL cause\n" "\n" "PATHOLOGICAL CAUSES:\n" " Endocrine: GH deficiency, Hypothyroidism, Cushing's\n" " Chromosomal: Turner (45,XO), Down, Noonan, Prader-Willi\n" " Skeletal: Achondroplasia, Rickets\n" " Systemic: Celiac disease, CKD, CHD, Thalassaemia\n" " Nutritional: SAM, malnutrition\n" " Psychosocial: Emotional deprivation (GH secretion impaired)" ) h3("Investigations") bullet("Bone age (X-ray left wrist/hand) — most important initial investigation") bullet("CBC, TFT (TSH, free T4), CMP (renal/liver function)") bullet("IGF-1, IGFBP-3 — proxy for GH status") bullet("Karyotype — Turner syndrome (all short girls)") bullet("Anti-tTG IgA — celiac disease") bullet("GH stimulation test (clonidine/insulin tolerance test)") bullet("MRI pituitary/brain — if GH deficiency confirmed") h3("Management") box( "Short Stature Identified\n" " │\n" " Bone Age + History + Exam\n" " │\n" " ┌────┴──────────────────────┐\n" " ▼ ▼\n" "Normal Bone Age Delayed Bone Age\n" " │ │\n" " ├─ Familial SS ┌───┴────────────────┐\n" " │ Reassurance ▼ ▼\n" " └─ Systemic cause GH Deficiency? CGD?\n" " Treat cause │ Reassurance\n" " rhGH Therapy" ) h2("Q4. Growth vs. Development — Differences and Factors Affecting Both") add_table( ["Feature","Growth","Development"], [ ["Definition","Increase in physical size","Acquisition of skills/functions"], ["Measurement","Quantitative (scales, tape)","Qualitative (milestones)"], ["Process","May stop at maturity","Continues throughout life"], ["Parameters","Weight, height, HC, BMI","Motor, language, social, cognitive"], ["Monitoring","Growth chart, Z-scores","DDST, developmental screening"], ] ) h3("Factors Affecting Growth and Development") body("Intrinsic factors:") bullet("Genetics (height potential)") bullet("Hormonal: GH, thyroid hormone, sex steroids, insulin, IGF-1") bullet("Gender: males grow taller") bullet("Intrauterine growth / birth weight") body("Extrinsic factors:") bullet("Nutrition — most important extrinsic factor") bullet("Socioeconomic status") bullet("Physical activity") bullet("Chronic illness / infections") bullet("Psychological and emotional security") bullet("Stimulation and learning opportunities") bullet("First 1000 days (conception to 2 years) = most critical window") h2("Q5. Age-independent Anthropometric Measurement (MUAC) and Management of SAM") h3("MUAC — Mid-Upper Arm Circumference") bullet("Measured at midpoint of left upper arm (between olecranon and acromion)") bullet("Age-independent for children 6 months–5 years") bullet("Reflects acute malnutrition (muscle + fat mass)") add_table( ["MUAC Value","Classification","Action"], [ ["≥ 12.5 cm","Normal","Routine care"], ["11.5–12.4 cm","MAM (Moderate Acute Malnutrition)","Supplementary feeding"], ["< 11.5 cm","SAM (Severe Acute Malnutrition)","Urgent therapeutic nutrition"], ] ) h3("WHO 10-Step Management of SAM") box( "PHASE 1 — STABILIZATION (Days 1–7)\n" " Step 1: Treat Hypoglycaemia → 10% glucose (10 mL/kg oral/IV)\n" " Step 2: Treat Hypothermia → Warm environment, KMC (skin-to-skin)\n" " Step 3: Treat Dehydration → ReSoMal (NOT standard ORS)\n" " Step 4: Correct Electrolytes → K+, Mg2+; AVOID Na loading\n" " Step 5: Treat Infections → Amoxicillin + Gentamicin IV/IM\n" " Step 6: Correct Micronutrients → Vit A (Day 1), Zinc, Folic acid\n" " DELAY iron until Phase 2 (rehabilitation)\n" " Step 7: Begin Cautious Feeding → F-75 (75 kcal/100 mL)\n" " Small frequent feeds every 2–3 hours\n" "\n" "PHASE 2 — REHABILITATION (Weeks 2–6)\n" " Step 8: Catch-up Growth → Switch to F-100 (100 kcal/100 mL)\n" " or RUTF (Ready-to-Use Therapeutic Food = Plumpy'Nut)\n" " Step 9: Sensory Stimulation → Play therapy, emotional support\n" " Step 10: Iron supplementation begins\n" "\n" "PHASE 3 — FOLLOW-UP (Community)\n" " Continue RUTF; monitor weight; nutritional counselling to parents\n" "\n" "Discharge criteria (WHO): MUAC ≥12.5 cm AND weight-for-height > −2 SD\n" "AND no oedema AND no acute illness AND good appetite" ) h2("Q6 & Q9. Growth and Development in First Year of Life + Milestones Table") add_table( ["Age","Gross Motor","Fine Motor","Language","Personal-Social"], [ ["2 months","Lifts head 45° prone","Opens fist; hands to midline","Cooing; social smile","Calms when held"], ["4 months","Rolls front to back; head steady","Holds rattle; reaches","Laughs; turns to voice","Recognises mother"], ["6 months","Sits with support; bears weight","Palmar grasp; transfers","Babbles; squeals","Stranger awareness begins"], ["9 months","Sits unsupported; crawls","Inferior pincer; bangs objects","Mama/dada non-specific","Separation anxiety; peek-a-boo"], ["12 months","Pulls to stand; cruises","TRUE pincer grasp","Mama/dada with meaning; 1–2 words; bye-bye","Pat-a-cake; drinks from cup"], ] ) h2("Q7. Growth Parameters — 1-year-old and 4-year-old") add_table( ["Parameter","At Birth","1 Year","4 Years"], [ ["Weight","~3 kg","~9 kg (birth wt × 3)","~16 kg"], ["Height","~50 cm","~75 cm (+25 cm from birth)","~100 cm (birth ht × 2)"], ["Head Circumference","34–35 cm","~46–47 cm","~50 cm"], ["Chest Circumference","~32 cm","~46 cm (= HC at 1 yr)","~52 cm"], ] ) body("Key Rules: Birth wt doubles at 4–5 months | triples at 12 months | quadruples at 2 years") body("Head circumference = Chest circumference at 1 year; after 1 year: Chest > Head") h2("Q10. Tanner Staging (Sexual Maturity Rating)") add_table( ["Stage","Females (Breast + Pubic Hair)","Males (Genitalia + Pubic Hair)"], [ ["1 (Prepubertal)","Papilla only; no pubic hair","Preadolescent; no pubic hair"], ["2","Breast bud; sparse pubic hair at labia","Testicular/scrotal enlargement; sparse pubic hair at base of penis"], ["3","Breast + areola enlarged; darker coarser pubic hair","Penile elongation; further testicular growth; coarser pubic hair"], ["4","Areola + papilla = secondary mound; adult-like but no thigh extension","Larger penis in width; adult-like pubic hair (no thigh extension)"], ["5 (Adult)","Adult breast; pubic hair adult pattern to medial thighs","Adult genitalia; pubic hair to thighs"], ] ) pagebreak() # ══════════════════════════════════════════════════════════════════════════════ # TOPIC 3 — DEVELOPMENTAL & BEHAVIORAL DISORDERS (p. 172) # ══════════════════════════════════════════════════════════════════════════════ h1("TOPIC 3: DEVELOPMENTAL AND BEHAVIORAL DISORDERS") body("Reference: Ghai Essential Pediatrics, 10th ed., pp. 44–50, 557") doc.add_paragraph() h2("Q1. Attention Deficit Hyperactivity Disorder (ADHD)") h3("Definition") body("ADHD is a neurodevelopmental disorder characterised by persistent inattention, impulsivity, and/or hyperactivity more frequent and severe than expected for developmental age — present in ≥ 2 settings and before age 12 years.") h3("DSM-5 Diagnostic Criteria") body("A. Inattention (≥6 of 9 symptoms for ≥6 months):") bullet("Fails to pay attention to details / careless mistakes") bullet("Difficulty sustaining attention in tasks") bullet("Does not listen when spoken to directly") bullet("Does not follow through on instructions") bullet("Difficulty organising activities") bullet("Avoids tasks requiring sustained mental effort") bullet("Often loses things needed for tasks") bullet("Easily distracted by extraneous stimuli") bullet("Often forgetful in daily activities") body("B. Hyperactivity/Impulsivity (≥6 of 9 symptoms for ≥6 months):") bullet("Fidgets/squirms; leaves seat when expected to remain seated") bullet("Runs/climbs in inappropriate situations ('on the go')") bullet("Talks excessively; blurts out answers; cannot wait turn") bullet("Interrupts or intrudes on others") h3("Subtypes: Combined (most common) | Predominantly Inattentive | Predominantly Hyperactive-Impulsive") h3("Management") box( " MANAGEMENT OF ADHD\n" " │\n" " ┌───────────────┼────────────────┐\n" " ▼ ▼ ▼\n" "PRESCHOOL SCHOOL-AGE ADOLESCENT\n" "(4–5 yrs) (6–18 yrs) (6–18 yrs)\n" " │ │ │\n" "Behavioral MEDICATION + Medication +\n" "Therapy Behavioral CBT +\n" "FIRST (no Therapy COMBINED Academic\n" "medication) support" ) add_table( ["Drug Class","Drug","Starting Dose","Notes"], [ ["Stimulant (1st line)","Methylphenidate (Ritalin)","0.3 mg/kg/dose","Short-acting; multiple doses daily"], ["Stimulant (1st line)","Methylphenidate ER (Concerta)","18 mg/day once","Once daily; preferred"], ["Non-stimulant (2nd line)","Atomoxetine (Strattera)","0.5 mg/kg/day","NE reuptake inhibitor; 4–6 weeks onset"], ["Non-stimulant","Clonidine ER","0.05 mg BD","Alpha-2 agonist; helps sleep"], ] ) h2("Q2. Physical and Behavioral Problems in Adolescents") add_table( ["Category","Problem","Management"], [ ["Physical","Acne vulgaris","Topical benzoyl peroxide, antibiotics, isotretinoin (severe)"], ["Physical","Obesity","Diet, exercise, CBT, metformin (metabolic syndrome)"], ["Physical","Dysmenorrhoea / menstrual irregularities","NSAIDs, OCP if needed"], ["Physical","Anaemia (esp. girls)","Iron supplementation, dietary advice"], ["Behavioral","Substance abuse","Motivational interviewing, CBT, de-addiction"], ["Behavioral","Risky sexual behaviour","Sex education, HPV vaccine, contraceptive counselling"], ["Behavioral","Depression / Anxiety","CBT, SSRIs (fluoxetine), school counselling"], ["Behavioral","Eating disorders","Multidisciplinary; nutritional rehab; family-based therapy"], ["Behavioral","Suicide ideation","Safety plan; hospitalisation if high risk; SSRIs"], ] ) body("HEADSSS Assessment: Home, Education, Activities, Drugs, Sexuality, Suicide/Depression, Safety") h2("Q3 & Q4. Breath-Holding Spells") h3("Definition") body("Paroxysmal episodes in young children (6 months–5 years) triggered by crying (emotional/painful stimulus) leading to apnoea, colour change, and potentially loss of consciousness. Peak age: 2 years. Prevalence ~5%.") h3("Types") add_table( ["Feature","Cyanotic (Common)","Pallid (Less common)"], [ ["Trigger","Frustration, anger, emotional upset","Sudden pain/fright (e.g., minor injury)"], ["Mechanism","Prolonged expiratory apnoea → cerebral hypoxia","Vagal reflex → cardiac asystole → hypoperfusion"], ["Colour","Cyanosis (blue)","Pallor (pale/white)"], ] ) h3("Typical Sequence (Flowchart)") box( "TRIGGER EVENT (pain / anger / frustration)\n" " ↓\n" " Child cries vigorously\n" " ↓\n" " Breath-holding in expiration\n" " ↓\n" " Colour change (cyanosis / pallor)\n" " ↓\n" " Loss of consciousness (brief)\n" " ↓\n" " Possible myoclonic jerks (anoxic seizure)\n" " ↓\n" " Gasping respirations return → Full recovery\n" " (Seconds–minutes; NO postictal phase)" ) h3("Management") bullet("Acute: Place supine; maintain airway; do NOT restrain; spontaneous recovery") bullet("Parent education and reassurance — MOST IMPORTANT") bullet("Avoid reinforcing triggers (consistent parenting)") bullet("Iron therapy — iron deficiency anaemia strongly associated; Fe supplementation reduces frequency significantly") bullet("Atropine (pallid type with documented vagally-mediated asystole)") bullet("Prognosis: Self-limiting, resolves by 5–6 years; 20% develop vasovagal syncope in adolescence") h2("Q5. Delayed Puberty in Girls — Definition, Clinical Features, Diagnosis") body("Delayed puberty in girls = Absence of breast development by age 13 years OR no menarche by 16 years with normal secondary sex characteristics OR no menarche within 4 years of breast development.") h3("Causes Classification") add_table( ["Category","Examples"], [ ["Constitutional Delay (~60%)","Most common; family history; spontaneous resolution"], ["Functional Hypogonadotropic Hypogonadism","Malnutrition, anorexia nervosa, excessive exercise, chronic illness, hypothyroidism"], ["Congenital Hypogonadotropic Hypogonadism","Kallmann syndrome (anosmia + hypogonadism), panhypopituitarism, craniopharyngioma"], ["Primary Gonadal Failure (Hypergonadotropic)","Turner syndrome (45,XO) — most common cause in girls; gonadal dysgenesis; post-chemo/radiation"], ] ) h3("Turner Syndrome — Key Features") bullet("Short stature (most consistent finding)") bullet("Webbed neck (pterygium colli); low posterior hairline") bullet("Shield chest; widely spaced nipples; cubitus valgus") bullet("Lymphoedema of hands/feet") bullet("Streak gonads (no spontaneous puberty)") bullet("Bicuspid aortic valve, coarctation of aorta") bullet("Horseshoe kidney; learning difficulties (math/spatial)") h3("Investigations") box( "DELAYED PUBERTY IN GIRLS\n" " │\n" " LH, FSH, Estradiol\n" " │\n" " ┌─────┴──────┐\n" " ▼ ▼\n" "LOW LH/FSH HIGH LH/FSH\n" "(Hypogonad- (Hypergonad-\n" " otropic) otropic)\n" " │ │\n" "Prolactin Karyotype\n" "IGF-1, IGFBP-3 (Turner 45,XO)\n" "MRI pituitary Pelvic U/S\n" "TSH, Free T4\n" "GnRH stim test" ) pagebreak() # ══════════════════════════════════════════════════════════════════════════════ # TOPIC 4 — FLUID AND ELECTROLYTE IMBALANCE (p. 172) # ══════════════════════════════════════════════════════════════════════════════ h1("TOPIC 4: FLUID AND ELECTROLYTE IMBALANCE") body("Reference: Ghai Essential Pediatrics, 10th ed., pp. 59–72") doc.add_paragraph() h2("Q1. SIADH — Syndrome of Inappropriate ADH Secretion") h3("Definition") body("SIADH = ADH is secreted autonomously (without osmotic stimulus) → excessive water retention → dilutional hyponatraemia + concentrated urine despite low serum osmolality.") h3("Bartter & Schwartz Diagnostic Criteria (ALL 5 required)") bullet("1. Serum Na < 130 mEq/L (hyponatraemia)") bullet("2. Serum osmolality < 275 mOsm/kg (hypo-osmolality)") bullet("3. Urine osmolality > 100 mOsm/kg (inappropriately concentrated)") bullet("4. Urine Na > 20 mEq/L (natriuresis despite hyponatraemia)") bullet("5. Euvolaemia + normal thyroid and adrenal function") h3("Causes") bullet("CNS: Meningitis, encephalitis, head injury, subarachnoid haemorrhage, brain tumour") bullet("Pulmonary: Pneumonia, TB, positive pressure ventilation") bullet("Malignancy (ectopic ADH): Small cell lung cancer, pancreatic Ca, lymphoma") bullet("Drugs: Carbamazepine, SSRIs, vincristine, cyclophosphamide, NSAIDs") bullet("Postoperative state, hypothyroidism, adrenal insufficiency") h3("Management") box( "SIADH Management\n" " │\n" " ┌────┴────────────────────────────────────┐\n" " ▼ ▼\n" "MILD/MODERATE SEVERE\n" "(Na > 120 mEq/L) (Na < 120 + symptoms)\n" " │ │\n" "Fluid restriction 3% Hypertonic Saline\n" "(800–1000 mL/day) 1–2 mL/kg/hr\n" " │ │\n" "Remove/treat cause CORRECT SLOWLY\n" " │ Max 8–10 mEq/L in 24 hrs\n" "Vaptans (Tolvaptan) │\n" "V2-receptor antagonist ⚠ Avoid OSMOTIC DEMYELINATION\n" " SYNDROME (>12 mEq/L in 24 hrs)" ) h2("Q2. Hypokalemia") body("Definition: Serum K+ < 3.5 mEq/L | Normal: 3.5–5.0 mEq/L") h3("Causes") bullet("Decreased intake: Malnutrition, inadequate TPN") bullet("GI losses: Vomiting, diarrhoea (cholera), NG suction, fistulae") bullet("Renal losses: Loop diuretics (most common), thiazides, hyperaldosteronism, RTA, Bartter/Gitelman syndrome") bullet("Transcellular shift: Insulin, alkalosis, beta-2 agonists, hypokalemic periodic paralysis") h3("ECG Changes (Progression)") box( "K+ falling:\n" "Normal → Flat T waves → Prominent U waves →\n" "ST depression → Wide QRS → Ventricular arrhythmias (VT/VF)\n" "\n" "Mnemonic: 'U wait for K' → U waves appear in hypokalemia" ) h3("Management") box( "Hypokalemia\n" " │\n" " ┌──┴──────────────────────────────────┐\n" " ▼ ▼\n" "Mild–Moderate Severe\n" "K+ 2.5–3.5 mEq/L K+ <2.5 or symptomatic\n" "(asymptomatic) │\n" " │ IV KCl infusion\n" "Oral KCl supplement Rate: ≤10 mEq/hr\n" "(40–80 mEq/day) Cardiac monitoring\n" "Dietary K+ (bananas, NEVER bolus IV KCl\n" "potatoes, fruits) → cardiac arrest!\n" " │\n" "⚠ CHECK MAGNESIUM — hypomagnesaemia causes refractory hypokalemia" ) h2("Q3. Hyperkalemia") body("Definition: Serum K+ > 5.5 mEq/L | Severe/life-threatening: > 7.0 mEq/L") h3("Causes") bullet("Renal failure (AKI/CKD) — most common") bullet("Addison's disease, congenital adrenal hyperplasia") bullet("ACE inhibitors, ARBs, K+-sparing diuretics (spironolactone)") bullet("Transcellular shift: Acidosis (pH ↓0.1 → K+ ↑0.6 mEq/L), insulin deficiency (DKA)") bullet("Cell breakdown: Rhabdomyolysis, haemolysis, tumour lysis syndrome, crush injury") h3("ECG Changes (Progressive)") box( "K+ Level │ ECG Change\n" "──────────┼───────────────────────────────────────────\n" "5.5–6.0 │ Peaked (tall, narrow, 'tented') T waves ← EARLIEST\n" "6.0–6.5 │ Prolonged PR; flattened P waves\n" "6.5–7.0 │ Widened QRS complex\n" ">7.0 │ P waves absent; sine wave pattern\n" ">8.0 │ VF / Asystole / Cardiac arrest\n" "\n" "Mnemonic: Peaked T → PR prolonged → QRS wide → Sine wave → DEAD" ) h3("Management (Emergency)") box( "EMERGENT MANAGEMENT (K+ > 6.5 or ECG changes)\n" " │\n" "STEP 1: Membrane Stabilisation\n" " 10% Calcium Gluconate 10 mL IV over 10 min\n" " (Onset: 1–3 min | Duration: 30–60 min)\n" " Does NOT lower K+ — only protects heart\n" " │\n" "STEP 2: Drive K+ into cells\n" " Insulin 10 units + 50 mL 50% Dextrose IV\n" " + NaHCO3 IV (if acidosis)\n" " + Nebulised salbutamol\n" " │\n" "STEP 3: Remove K+ from body\n" " Furosemide IV (if urine output adequate)\n" " Kayexalate (Na polystyrene sulfonate) PO/PR\n" " Dialysis (if renal failure or unresponsive)" ) h2("Q4. Hyponatremia & Management of 1-year-old with Na 115 mEq/L") body("Definition: Serum Na < 135 mEq/L | Severe symptomatic: < 120 mEq/L") h3("Classification by Volume Status") box( "HYPONATREMIA\n" " │\n" "┌─────┼─────────────┐\n" "▼ ▼ ▼\n" "HYPOVOLAEMIC EUVOLAEMIC HYPERVOLAEMIC\n" " (Low TBW) (Normal TBW) (High TBW)\n" " │ │ │\n" "Diuretics, SIADH, CHF,\n" "Addison's, Hypothyroid, Cirrhosis,\n" "V/D/Burns Psychogenic CKD/AKI\n" " polydipsia Nephrotic Synd." ) h3("Clinical Features") bullet("Na 125–135: Often asymptomatic") bullet("Na 120–125: Headache, nausea, confusion, restlessness") bullet("Na 110–120: Disorientation, seizures, obtundation") bullet("Na < 110: Coma, cerebral herniation, death") h3("Management of 1-year-old with Na 115 mEq/L") body("Severity: SEVERE symptomatic hyponatraemia (Na < 120 mEq/L)") bullet("3% NaCl: 2 mL/kg IV bolus; repeat if seizures persist") bullet("Target: Raise Na by 5 mEq/L in first 1–2 hours to control symptoms") bullet("Then SLOW CORRECTION: Max 8–10 mEq/L in 24 hours total") bullet("Na deficit = 0.6 × weight (kg) × (desired Na − actual Na)") bullet("For 10 kg child: 0.6 × 10 × (130 − 115) = 90 mEq → use 3% NaCl (513 mEq/L) ≈ 175 mL over 12–24 hrs") bullet("Monitor Na every 2 hours; identify and treat cause (SIADH, meningitis)") bullet("AVOID correction > 12 mEq/L per 24 hours → risk of Osmotic Demyelination Syndrome") h2("Q5. Hypernatremia") body("Definition: Serum Na > 145 mEq/L | Always indicates relative water deficit") h3("Causes") bullet("Water loss > Na loss: Diabetes insipidus, excessive sweating, fever, diarrhoea in infants, hyperventilation") bullet("Inadequate water intake: Infants unable to ask for water; altered thirst (hypodipsia)") bullet("Excess Na intake: Hypertonic formula, NaHCO3 overdose, hyperaldosteronism") h3("Management") box( "HYPERNATRAEMIA\n" " │\n" "Phase 1: Restore circulating volume\n" " Normal Saline (0.9%) if haemodynamically unstable\n" " │\n" "Phase 2: Slowly replace water deficit\n" " 0.45% NaCl or 5% Dextrose orally/via NG\n" " Correct Na by MAX 10–12 mEq/L per 24 hours\n" " │\n" "⚠ DANGER of rapid correction: CEREBRAL OEDEMA\n" " │\n" "Central DI → dDAVP (desmopressin)\n" "Nephrogenic DI → Thiazides + low Na/protein diet\n" "\n" "Water Deficit (L) = 0.6 × wt (kg) × [(serum Na / 145) – 1]\n" "Replace 50% in first 24 hrs + maintenance\n" "Replace remaining 50% over next 24–48 hrs" ) pagebreak() print("Part 1 written successfully (Topics 1-4)") doc.save("/tmp/workspace/pediatrics-answerbook/part1.docx") PYEOF
python3 << 'PYEOF' from docx import Document from docx.shared import Pt, Inches, RGBColor from docx.enum.text import WD_ALIGN_PARAGRAPH doc = Document("/tmp/workspace/pediatrics-answerbook/part1.docx") def h1(text): p = doc.add_heading(text, level=1) p.runs[0].font.color.rgb = RGBColor(0x1F, 0x49, 0x7D) def h2(text): p = doc.add_heading(text, level=2) p.runs[0].font.color.rgb = RGBColor(0x2E, 0x74, 0xB5) def h3(text): p = doc.add_heading(text, level=3) p.runs[0].font.color.rgb = RGBColor(0x00, 0x70, 0xC0) def body(text): doc.add_paragraph(text) def bullet(text): doc.add_paragraph(text, style="List Bullet") def box(text): p = doc.add_paragraph() p.style = doc.styles["No Spacing"] run = p.add_run(text) run.font.name = "Courier New" run.font.size = Pt(9) doc.add_paragraph() def add_table(headers, rows): t = doc.add_table(rows=1+len(rows), cols=len(headers)) t.style = "Light List Accent 1" hrow = t.rows[0].cells for i,h in enumerate(headers): hrow[i].text = h for run in hrow[i].paragraphs[0].runs: run.bold=True for ri,row in enumerate(rows): cells = t.rows[ri+1].cells for ci,val in enumerate(row): cells[ci].text=val doc.add_paragraph() def pagebreak(): doc.add_page_break() # ══════════════════════════════════════════════════════════════════════════════ # TOPIC 5 — NUTRITION AND RELATED DISEASES (pp. 172-174) # ══════════════════════════════════════════════════════════════════════════════ h1("TOPIC 5: NUTRITION AND RELATED DISEASES") body("Reference: Ghai Essential Pediatrics, 10th ed., pp. 82–114") h2("Q1 & Q2 & Q3. SAM / PEM — Classification, Clinical Features, Management") h3("WHO Classification of PEM") add_table( ["Type","Clinical Features","Pathophysiology"], [ ["Marasmus","Severe wasting; no oedema; 'old man face'; baggy pants appearance; alert but irritable; skin and bone","Severe calorie + protein deficiency; fat + muscle catabolism"], ["Kwashiorkor","Oedema (hallmark); skin changes; hair changes (flag sign); hepatomegaly; apathetic; moon face","Primarily protein deficiency; hypoalbuminaemia → oedema"], ["Marasmic Kwashiorkor","Features of both: wasting + oedema; most severe","Combined calorie + severe protein deficiency"], ] ) h3("WHO SAM Criteria (Any ONE = SAM)") bullet("MUAC < 11.5 cm (6 months–5 years)") bullet("Weight-for-height < −3 SD (Z-score)") bullet("Bilateral pitting pedal oedema (nutritional)") h3("WHO 10-Step Management of SAM") box( "PHASE 1 — STABILIZATION (Days 1–7) TARGET\n" " Step 1: Treat Hypoglycaemia BGL > 3 mmol/L\n" " → 10% glucose/dextrose 50 mL oral/NG\n" " OR 10% dextrose 5 mL/kg IV (if unconscious)\n" " Step 2: Treat Hypothermia Temp > 36.5°C\n" " → Warm environment, Kangaroo Mother Care\n" " Step 3: Treat Dehydration Use ReSoMal only\n" " → 5 mL/kg/30 min × 2 → 10 mL/kg/hr (NOT standard ORS)\n" " Step 4: Correct Electrolytes K+ and Mg2+ only\n" " → AVOID Na loading; give K+/Mg2+ NO Na supplements\n" " Step 5: Treat/Prevent Infections\n" " → Amoxicillin 50 mg/kg/day PO 5 days\n" " + Gentamicin 7.5 mg/kg IM/IV OD if severe\n" " Step 6: Correct Micronutrient Deficiencies\n" " → Vit A (Day 1): 50,000–200,000 IU based on age\n" " → Zinc 2 mg/kg/day, Folic acid 5 mg (Day 1) then 1 mg/day\n" " → DELAY IRON until Phase 2 (rehabilitation)\n" " Step 7: Begin Cautious Feeding → F-75\n" " → 75 kcal + 0.9 g protein / 100 mL\n" " → Every 2 hrs (12 feeds/day); 100 mL/kg/day\n" "\n" "PHASE 2 — REHABILITATION (Weeks 2–6)\n" " Step 8: Achieve Catch-up Growth\n" " → Switch F-75 to F-100 (100 kcal/100 mL)\n" " → OR RUTF = Ready-to-Use Therapeutic Food (Plumpy'Nut)\n" " → 150–220 kcal/kg/day; goal: wt gain > 10 g/kg/day\n" " Step 9: Sensory Stimulation & Emotional Support\n" " → Play therapy 15–30 min/day; structured play activities\n" " Step 10: Iron supplementation begins in Phase 2\n" " → Elemental iron 3 mg/kg/day\n" "\n" "PHASE 3 — FOLLOW-UP (Community)\n" " Continue RUTF/F-100; nutritional counselling; growth monitoring\n" "\n" "DISCHARGE CRITERIA (WHO):\n" " MUAC ≥ 12.5 cm AND weight-for-height > −2 SD\n" " AND no oedema AND no acute illness AND good appetite" ) h3("Nutritional Management of Severely Wasted 1-year-old (5 kg)") body("Child is 1 year old, weight 5 kg (expected ~9 kg) → severely malnourished") bullet("Calculate ideal body weight (IBW) for height, NOT actual weight for fluid/drug calculations") bullet("F-75: 100 mL/kg/day × IBW = ~6–7 kg × 100 = 600–700 mL/day in 12 divided feeds") bullet("Phase 2: F-100 or RUTF at 150–220 kcal/kg/day IBW") bullet("Monitor: Weight daily (target > 10 g/kg/day in rehabilitation phase)") bullet("Admit to Nutritional Rehabilitation Centre (NRC) if inpatient criteria met") h2("Q6. Vitamin D — Synthesis and Rickets") h3("Synthesis of Vitamin D") box( "SUNLIGHT (UV-B)\n" " ↓\n" "Skin: 7-dehydrocholesterol → Cholecalciferol (Vit D3)\n" " ↓\n" "Liver: Cholecalciferol → 25-hydroxycholecalciferol [25(OH)D3]\n" " (First hydroxylation) — storage form\n" " ↓\n" "Kidney: 25(OH)D3 → 1,25-dihydroxycholecalciferol [1,25(OH)2D3]\n" " (Second hydroxylation by 1α-hydroxylase)\n" " = CALCITRIOL (active form)\n" " ↓\n" "Actions: ↑ intestinal Ca2+ absorption\n" " ↑ renal Ca2+ reabsorption\n" " ↑ bone mineralisation" ) h3("Rickets — Clinical Features") body("Rickets = inadequate mineralisation of osteoid in growing bone (children); Osteomalacia = in adults") bullet("General: Irritability, restlessness, hypotonia, failure to thrive, sweating of head") bullet("Head: Craniotabes (ping-pong ball sensation in skull); frontal and parietal bossing; delayed fontanelle closure; delayed dentition") bullet("Chest: Rickety rosary (beading at costochondral junctions); Harrison's sulcus (grooved indentation); pigeon chest") bullet("Limbs: Bow legs (genu varum) — most common in toddlers; knock knees (genu valgum) in older children; widened wrists/ankles (metaphyseal widening)") bullet("Complications: Pathological fractures; growth retardation; hypocalcaemic seizures; laryngospasm; cardiomyopathy") h3("Investigations") add_table( ["Test","Finding in Rickets"], [ ["Serum Ca2+","Low (hypocalcaemia) or normal"], ["Serum P","Low (hypophosphataemia)"], ["ALP (Alkaline Phosphatase)","HIGH (hallmark — osteoblastic activity)"], ["25(OH)D3","Low (< 20 ng/mL = deficiency)"], ["PTH","Elevated (secondary hyperparathyroidism)"], ["X-ray wrist","Cupping, fraying, widening of metaphysis; Looser zones"], ] ) h3("Management") bullet("Vitamin D: Stoss therapy — 3,00,000–6,00,000 IU single oral dose (India)") bullet("OR: Daily oral Vitamin D3 2,000–4,000 IU/day × 3 months") bullet("Calcium supplementation: 500–1000 mg/day elemental Ca") bullet("Sun exposure: 30 min/day with limbs exposed") bullet("Treat hypocalcaemia first (if symptomatic/seizures): IV calcium gluconate 2 mL/kg slow IV") h2("Q7. Radiological Findings in Scurvy") body("Scurvy = Vitamin C deficiency → impaired collagen synthesis → bone and vascular changes") h3("X-ray Findings in Scurvy") bullet("Trummerfeld (Debris) zone: Zone of rarefaction/destruction at metaphysis — PATHOGNOMONIC") bullet("Frankel's white line: Dense line at metaphysis due to provisional zone of calcification (thick and bright)") bullet("Pelkan spur / Wimberger ring sign: Corner sign (subperiosteal haemorrhage at metaphyseal corners)") bullet("Ground glass osteoporosis of shaft (general rarefaction)") bullet("Periosteal elevation with subperiosteal haematoma") bullet("Pseudoparalysis: Child refuses to move limb due to pain from subperiosteal haemorrhage (looks like paralysis)") h3("Clinical Features of Scurvy") bullet("Irritability; tender limbs (pseudoparalysis)") bullet("Perifollicular haemorrhage; corkscrew hairs") bullet("Bleeding gums; gum hyperplasia (only in children with erupted teeth)") bullet("Woody oedema of legs") bullet("Haemarthrosis; anaemia") h3("Management: Ascorbic acid 300–500 mg/day for 4 weeks; maintenance 30–50 mg/day") h2("Q8. Classification of PEM (Gomez / Waterlow)") add_table( ["Classification","Criterion","Grade I","Grade II","Grade III"], [ ["Gomez (weight-for-age)","% of median","75–90%","60–74%","< 60%"], ["Waterlow Wasting (wt-for-ht)","% of median","80–89%","70–79%","< 70%"], ["Waterlow Stunting (ht-for-age)","% of median","90–94%","85–89%","< 85%"], ] ) h2("Q10. Pseudoparalysis") bullet("Definition: A condition where the child refuses to move a limb, mimicking paralysis, due to pain — NOT true neurological paralysis") bullet("Causes in children: Scurvy (subperiosteal haemorrhage — most classic), Congenital syphilis, Osteomyelitis/septic arthritis, Pathological fracture, Birth injury (Erb's palsy / fracture clavicle)") bullet("In scurvy: Limbs fixed in 'frog-leg' position; periosteal haemorrhage → extreme tenderness → pseudoparalysis") bullet("Diagnosis: X-ray shows Trummerfeld zone, Pelkan spur; Serum Vitamin C low") h2("Q11. Refractory Rickets") body("= Rickets that does not respond to conventional Vitamin D doses") add_table( ["Type","Defect","Treatment"], [ ["Vitamin D-resistant rickets (Hypophosphataemic rickets / X-linked)","Renal phosphate wasting (PHEX mutation); X-linked dominant","Oral phosphate + Calcitriol (NOT Vitamin D alone)"], ["Vit D-dependent Rickets Type I (VDDR-I)","↓ 1α-hydroxylase (renal)","Calcitriol (1,25(OH)2D3) supplement"], ["Vit D-dependent Rickets Type II (VDDR-II)","Resistance to 1,25(OH)2D3 (VDR mutation)","Very high-dose Calcitriol + IV Ca infusion"], ["Renal Osteodystrophy","CKD → ↓ 1α-hydroxylase","Treat CKD; Calcitriol; phosphate binders"], ["Oncogenic rickets (TIO)","FGF-23 excess from tumour","Resect tumour; phosphate + Calcitriol"], ] ) h2("Q12. Complementary Feeding") body("= Introduction of solid/semi-solid foods alongside continued breastfeeding, starting at 6 months of age") h3("WHO/IAP Recommendations") bullet("Start at exactly 6 months (not before 4 or after 6 months)") bullet("Continue breastfeeding up to 2 years and beyond") bullet("Foods should be: energy-dense, iron-rich, culturally appropriate") bullet("Avoid: Salt, sugar, honey (botulism risk), cow's milk as main drink before 1 year, fruit juices") h3("Principles of Complementary Feeding (AFASS — WHO)") bullet("Appropriate: Meets nutritional needs") bullet("Frequency: Age-appropriate (2×/day at 6–8 months → 3×/day at 9–11 months → 3–4×/day at 12–24 months)") bullet("Amount: Start 2–3 spoonfuls → increase gradually") bullet("Safe: Hygienically prepared") bullet("Specific: Iron-rich foods — dal, meat, fortified cereal, eggs") body("Key: Iron stores from birth depleted by 6 months → complementary foods MUST be iron-rich") h2("Q13. Vitamin A Deficiency — Clinical Signs and Treatment") h3("Bitot's Spots and Xerophthalmia Staging (WHO)") add_table( ["Stage","Clinical Finding"], [ ["X1A","Night blindness (earliest symptom — functional)"], ["X1B","Conjunctival xerosis (dry, wrinkled conjunctiva)"], ["X2","Bitot's spots (foamy, cheesy white spots on bulbar conjunctiva — PATHOGNOMONIC)"], ["X3A","Corneal xerosis (dry, hazy cornea)"], ["X3B","Corneal ulceration/keratomalacia — MEDICAL EMERGENCY; can cause blindness"], ["XS","Corneal scar"], ["XN","Night blindness only"], ["XF","Xerophthalmic fundus"], ] ) h3("Treatment — Vitamin A (National Protocol, India)") bullet("Day 1: Vitamin A oral dose by age — <6 months: 50,000 IU; 6–12 months: 1,00,000 IU; >12 months: 2,00,000 IU") bullet("Day 2: Same dose repeated") bullet("Day 15 (2 weeks later): Third dose") bullet("For corneal involvement: Treat also as emergency; cover eye; refer ophthalmology") bullet("Prevention: Vit A supplementation every 6 months under NHM (9 months to 5 years)") pagebreak() # ══════════════════════════════════════════════════════════════════════════════ # TOPIC 6 — NEONATOLOGY (pp. 174-177) # ══════════════════════════════════════════════════════════════════════════════ h1("TOPIC 6: NEONATOLOGY") body("Reference: Ghai Essential Pediatrics, 10th ed., pp. 121–175") h2("Q1. Exclusive Breastfeeding") bullet("Definition: Infant receives ONLY breast milk — no other liquids, solids, or water — for the first 6 months of life") bullet("Exception: Oral rehydration salts, drops, syrups (vitamins/minerals) are allowed") h3("Composition Advantages of Breast Milk") add_table( ["Component","Breast Milk Advantage"], [ ["Immunoglobulins","sIgA — protects gut against pathogens; IgM, IgG"], ["Lactoferrin","Antimicrobial; iron-binding; anti-inflammatory"], ["Lysozyme","Bactericidal enzyme"], ["Living cells","Macrophages, lymphocytes, neutrophils"], ["Bifidus factor","Promotes Lactobacillus bifidus growth (healthy gut flora)"], ["Long-chain fatty acids","DHA, ARA — brain development"], ["Whey:Casein ratio","60:40 (vs. cow's milk 20:80) — easier digestion"], ] ) h3("Advantages of Breastfeeding") bullet("CHILD: Protection against infections (diarrhoea, LRTI, UTI, otitis media, sepsis); lower risk of SIDS; lower risk of obesity, T1DM, T2DM, hypertension, allergies; better IQ/cognitive development") bullet("MOTHER: Faster uterine involution; reduced PPH; contraceptive effect (LAM); lower risk of breast and ovarian cancer; promotes bonding") bullet("SOCIAL: Cost-effective; always available; correct temperature; reduces healthcare costs") h3("Lactation Failure — Causes and Management") bullet("Causes: Inadequate suckling; poor latch; breast engorgement; mastitis; maternal illness/fatigue; maternal anxiety; supplementation with formula; inverted nipple") bullet("Management: Correct latch technique; frequent feeding (8–12 times/24 hrs); avoid bottles/dummies; breast massage; kangaroo care; support group; domperidone (galactogogue) if needed; treat mastitis with antibiotics") h2("Q2. Algorithm for Neonatal Resuscitation (NRP — IAP/AHA)") box( "BIRTH\n" " ↓\n" "Initial Assessment (in first 30 seconds):\n" " • Term gestation? • Breathing/crying? • Good tone?\n" " ↓\n" "ALL YES → Routine care (warm, dry, stimulate; skin-to-skin)\n" " ↓\n" "ANY NO → Warm, Clear airway if needed, Dry, Stimulate (30 sec)\n" " ↓\n" "Assess: HR + Breathing/Effort\n" " ↓\n" "Breathing / HR > 100 → Laboured breathing / low O2 sat?\n" " YES → O2 + Consider CPAP\n" " ↓\n" "Apnoea / gasping / HR < 100 → PPV (Positive Pressure Ventilation)\n" " Bag-mask ventilation at 40–60 breaths/min; SpO2 monitor\n" " (30 sec of PPV)\n" " ↓\n" "HR still < 100 → Check chest rise; correct mask seal; reposition airway\n" " ↓\n" "HR < 60 despite PPV → Chest compressions\n" " Ratio: 3 compressions : 1 ventilation (90 compressions + 30 breaths/min)\n" " Depth: 1/3 AP diameter of chest\n" " ↓\n" "HR still < 60 → Intubate + IV Adrenaline (Epinephrine)\n" " Epinephrine: 0.1–0.3 mL/kg of 1:10,000 IV/UVC\n" " OR 0.5–1 mL/kg ET (higher dose for ET route)\n" " ↓\n" "Consider: Volume expander (Normal Saline 10 mL/kg IV)\n" " Sodium bicarbonate (if prolonged arrest with metabolic acidosis)" ) h3("Apgar Score") add_table( ["Feature","0","1","2"], [ ["Appearance (colour)","Blue/pale all over","Blue extremities, pink body","Pink all over"], ["Pulse (HR)","Absent","< 100 bpm","≥ 100 bpm"], ["Grimace (reflex)","No response","Grimace only","Cry / cough / sneeze"], ["Activity (tone)","Limp","Some flexion","Active flexion"], ["Respiration","Absent","Slow/irregular","Good/crying"], ] ) bullet("Scored at 1 min and 5 min after birth") bullet("Score 7–10: Normal | 4–6: Moderate depression | 0–3: Severe depression / asphyxia") bullet("1-min score: Indicates need for immediate resuscitation") bullet("5-min score: Indicator of outcome/prognosis") h2("Q3 & Q4. Neonatal Jaundice — Causes, Management, Brain Damage Features") h3("Causes of Neonatal Jaundice by Timing") add_table( ["Timing","Causes"], [ ["< 24 hours (ALWAYS PATHOLOGICAL)","Rh incompatibility (HDN), ABO incompatibility, G6PD deficiency, congenital infection (TORCH), sepsis"], ["2–7 days (Physiological)","Physiological jaundice (immature liver enzymes + fetal Hb breakdown + ↑ enterohepatic circulation)"], ["> 14 days (Prolonged)","Breastmilk jaundice, hypothyroidism, biliary atresia, neonatal hepatitis, G6PD deficiency, sepsis, UGT1A1 mutation"], ] ) h3("Management — Phototherapy") bullet("Indication: Serum bilirubin above treatment threshold (TSB charts by gestational age and postnatal age)") bullet("Mechanism: Photoisomerisation of bilirubin (unconjugated, fat-soluble) to water-soluble lumirubin → excreted in bile and urine WITHOUT glucuronidation") bullet("Complications of phototherapy: Loose stools, skin rash, bronze baby syndrome (in conjugated hyperbilirubinemia), retinal damage (hence eye cover essential), hyperthermia, dehydration, calcium oxalate deposits in skin") h3("Exchange Transfusion") bullet("Indicated: TSB above exchange threshold; hydrops fetalis; symptomatic despite phototherapy") bullet("Volume: Double volume exchange (2 × 85 mL/kg = 170 mL/kg)") bullet("Blood: O-negative or cross-matched; fresh packed cells reconstituted to Hct 50–60%") h3("Features of Brain Damage from Bilirubin (Kernicterus / BIND)") box( "ACUTE BILIRUBIN ENCEPHALOPATHY (BIND Score)\n" "\n" "Phase 1 (Early, Reversible):\n" " • Hypotonia, lethargy, poor suck, high-pitched cry\n" "\n" "Phase 2 (Intermediate):\n" " • Hypertonia alternating with hypotonia\n" " • Retrocollis (neck arching) + Opisthotonus (back arching)\n" " • Fever, seizures, high-pitched cry\n" " • 'Setting sun' sign (tonically downward deviated eyes)\n" "\n" "Phase 3 (Advanced, Irreversible):\n" " • Pronounced hypertonia\n" " • Spasm, apnoea, coma\n" "\n" "CHRONIC KERNICTERUS (Bilirubin-Induced Neurological Dysfunction):\n" " • Choreoathetotic cerebral palsy (MOST characteristic)\n" " • Sensorineural hearing loss (auditory neuropathy)\n" " • Upward gaze palsy\n" " • Enamel dysplasia of deciduous teeth\n" " • Normal intelligence in most (unlike other CP types)" ) h2("Q5. Differential Diagnosis of Cyanosis in Newborn") box( "CYANOSIS IN NEWBORN\n" " │\n" " ▼\n" " Central or Peripheral?\n" " │\n" " ┌─────┴───────────────────────────────────┐\n" " ▼ ▼\n" "CENTRAL CYANOSIS PERIPHERAL CYANOSIS\n" "(blue mucous membranes) (blue extremities only)\n" " │ (Acrocyanosis — NORMAL at birth)\n" " ▼\n" "HYPEROXIA TEST (give 100% O2 × 10 min)\n" " │\n" " ┌──────────────────────────────────┐\n" " ▼ ▼\n" "PaO2 DOES NOT RISE PaO2 RISES > 150 mmHg\n" "(< 100 mmHg) = CARDIAC CAUSE = RESPIRATORY CAUSE\n" "\n" "CARDIAC (Cyanotic CHD): RESPIRATORY:\n" "• TGA (Transposition of • RDS (Hyaline Membrane Disease)\n" " Great Arteries) — most common • Meconium aspiration syndrome\n" " in newborns • TTN (Transient Tachypnoea)\n" "• Tetralogy of Fallot • Pneumonia/sepsis\n" "• Pulmonary atresia • Pneumothorax\n" "• Tricuspid atresia • Diaphragmatic hernia\n" "• Total anomalous pulmonary • Upper airway obstruction\n" " venous return (TAPVR)\n" "• Truncus arteriosus\n" "\n" "OTHER:\n" "• Methaemoglobinaemia\n" "• Polycythaemia\n" "• Persistent Pulmonary Hypertension of Newborn (PPHN)\n" "• Central nervous system disease (apnoea)" ) h2("Q8. Handicaps of LBW Baby") h3("Short-term Problems") bullet("Hypothermia: Poor subcutaneous fat + large surface area to body weight ratio") bullet("Hypoglycaemia: Low glycogen stores + poor gluconeogenesis") bullet("Respiratory Distress Syndrome: Surfactant deficiency (most in < 34 weeks)") bullet("Infection/Sepsis: Poor immunological defences; immature skin barrier") bullet("Intraventricular Haemorrhage (IVH): Fragile germinal matrix vessels") bullet("Necrotising Enterocolitis (NEC): Immature gut; bacterial invasion") bullet("Metabolic: Hypocalcaemia, hyponatraemia, acidosis, hyperbilirubinaemia") bullet("Poor feeding: Poor suck-swallow-breathe coordination; nasogastric feeds needed") h3("Long-term Problems (Handicaps)") bullet("Neurodevelopmental delay: Cerebral palsy, intellectual disability, learning disability") bullet("Hearing loss: Sensorineural (IVH, gentamicin, hyperbilirubinaemia)") bullet("Visual impairment: Retinopathy of prematurity (ROP)") bullet("Chronic lung disease (Bronchopulmonary dysplasia): In those requiring prolonged O2") bullet("Growth: Short stature; catch-up growth varies") bullet("Behavioural: ADHD, anxiety; lower academic achievement") bullet("Adult diseases (Barker hypothesis): Higher risk of HTN, T2DM, CAD, metabolic syndrome") h2("Q14. Respiratory Distress Syndrome (RDS) / Hyaline Membrane Disease (HMD)") h3("Pathophysiology") box( "Prematurity (< 34 weeks)\n" " ↓\n" "Surfactant deficiency\n" "(surfactant produced by Type II pneumocytes from ~28 wks; mature by 34–36 wks)\n" " ↓\n" "Alveolar surface tension ↑\n" " ↓\n" "Alveolar collapse (atelectasis) at end-expiration\n" " ↓\n" "Decreased lung compliance + Hypoxia\n" " ↓\n" "↑ Respiratory effort → Exhaustion → Worsening atelectasis\n" " ↓\n" "Hypoxia + Acidosis → Pulmonary vasoconstriction\n" " ↓\n" "Right-to-left shunting (through PDA + foramen ovale) → Worsening hypoxia\n" " ↓\n" "Plasma exudate fills alveoli → Hyaline membrane formation\n" "(eosinophilic membrane lining terminal airways — HISTOLOGICAL HALLMARK)" ) h3("Clinical Features") bullet("Onset: Within first few hours of birth (usually < 4 hours)") bullet("Tachypnoea (RR > 60), grunting, nasal flaring, intercostal/subcostal retractions") bullet("Cyanosis increasing despite O2") bullet("Sternal retraction; poor air entry on auscultation") bullet("Worsens in first 48–72 hours then gradually improves (if survives)") h3("Investigations") bullet("X-ray chest: Ground glass opacity (granular/reticulogranular pattern); air bronchograms; reduced lung volume") bullet("ABG: Hypoxia (PaO2 < 50 mmHg), hypercarbia, respiratory + metabolic acidosis") bullet("L/S ratio (Lecithin/Sphingomyelin): < 2.0 = lung immaturity") bullet("Shake/bubble test: Negative = surfactant deficiency") h3("Management") box( "RDS MANAGEMENT\n" " │\n" "Prevention (if preterm delivery expected < 34 wks):\n" " → Antenatal corticosteroids: Betamethasone 12 mg IM × 2 doses (24 hrs apart)\n" " → Reduces RDS incidence by ~50% if given 24 hrs to 7 days before delivery\n" " │\n" "Supportive Care:\n" " → Warmth: Incubator/radiant warmer\n" " → Minimal handling\n" " → Monitor glucose, temperature, BP\n" " │\n" "Oxygen Therapy:\n" " → CPAP (Continuous Positive Airway Pressure): FIRST LINE\n" " • Keeps alveoli open at end-expiration\n" " • PEEP 4–8 cmH2O; FiO2 to maintain SpO2 90–95%\n" " → Mechanical Ventilation: If CPAP fails (rising CO2, increasing apnoea)\n" " │\n" "Surfactant Replacement Therapy (SRT):\n" " → Intratracheal instillation via ET tube\n" " → Natural surfactant preferred: Beractant (Survanta) or Poractant alfa (Curosurf)\n" " → Prophylactic (< 27 weeks): Within 30 min of birth\n" " → Rescue (> 27 weeks): When FiO2 > 0.3 needed on CPAP\n" " → INSURE technique: Intubate-Surfactant-Extubate (back to CPAP)\n" " │\n" "Monitor for complications:\n" " → IVH, PDA, air leak (pneumothorax), BPD, NEC, sepsis" ) h2("Q16. Phototherapy — Mechanism, Indications, Complications") h3("Mechanism of Action") box( "Unconjugated Bilirubin (fat-soluble, crosses BBB) in skin\n" " ↓ (Blue-green light 400–520 nm; peak 450 nm)\n" "PHOTOISOMERISATION\n" " → Configurational isomers (Z-Z → E-Z bilirubin) — reversible; excreted in bile\n" " → Structural isomer (lumirubin) — IRREVERSIBLE; water-soluble;\n" " excreted in bile + urine WITHOUT hepatic conjugation\n" " ↓\n" "↓ Serum bilirubin (by ~1–2 mg/dL per hour with intensive phototherapy)" ) h3("Indications") bullet("Term neonate: TSB > 15 mg/dL (day 3–5); see AAP 2022 nomogram for exact thresholds by age") bullet("Preterm neonate: Lower thresholds (e.g., TSB > 10 mg/dL in very preterm)") bullet("Any neonate with jaundice in first 24 hours (investigate cause urgently)") h3("Complications of Phototherapy") bullet("Loose green stools (bile pigments)") bullet("Skin rash / erythema; hyperthermia; dehydration (increased insensible water loss ~15%)") bullet("Bronze baby syndrome: Grey-brown discolouration in infants with conjugated hyperbilirubinemia (contraindication to phototherapy)") bullet("Retinal damage (hence opaque eye covers mandatory)") bullet("Separates mother and baby; may interfere with breastfeeding") h2("Q17. Neonatal Sepsis") h3("Definition") body("Neonatal sepsis = systemic infection in a neonate (< 28 days) characterised by clinical signs of infection with or without a positive blood culture.") add_table( ["Feature","Early-Onset Sepsis (EOS)","Late-Onset Sepsis (LOS)"], [ ["Age","< 72 hours (or < 7 days)","≥ 72 hours (or > 7 days)"], ["Source","Vertical transmission (mother → baby intrapartum)","Horizontal — nosocomial or community"], ["Organisms","GBS (Group B Streptococcus), E. coli, Listeria, Klebsiella","Staphylococcus aureus, CONS, Pseudomonas, Klebsiella, fungi"], ["Risk factors","Prolonged ROM, chorioamnionitis, maternal fever, prematurity","Central lines, invasive procedures, prematurity, crowded NICU"], ] ) h3("Clinical Features — WATCH FOR:") bullet("Temperature instability (hypothermia more common in neonates than fever)") bullet("Feeding difficulties: Poor feeding, vomiting, feed intolerance, abdominal distension") bullet("Apnoea, tachypnoea, grunting, desaturation") bullet("Colour changes: Pallor, mottling, jaundice, cyanosis") bullet("Neurological: Irritability, lethargy, seizures, bulging fontanelle") bullet("Circulation: Tachycardia, poor perfusion, capillary refill time > 3 sec, hypotension") h3("Investigations") bullet("Blood culture (gold standard) × 2 — before starting antibiotics") bullet("CBC: WBC (leucocytosis or leucopenia), neutrophil count (ANC), I:T ratio > 0.2 (toxic)") bullet("CRP > 10 mg/L (rises 12–24 hrs after onset); Procalcitonin (more sensitive)") bullet("CSF (if clinically indicated): Cell count, protein, glucose, culture") bullet("Blood glucose, electrolytes, ABG") h3("Management") bullet("Ampicillin + Gentamicin: First-line for EOS (covers GBS, E. coli, Listeria)") bullet("Vancomycin + Gentamicin: If MRSA suspected or in NICU (LOS)") bullet("Duration: 10–14 days (culture-positive); 7–10 days (culture-negative clinical sepsis)") bullet("Supportive: Temperature, glucose, fluid, respiratory, circulatory support") h2("Q18. Antenatal Corticosteroids in Preterm Labour") h3("Drug and Dose") bullet("Betamethasone: 12 mg IM every 24 hours × 2 doses (preferred — crosses placenta better)") bullet("Dexamethasone: 6 mg IM every 12 hours × 4 doses (alternative)") h3("Indications") bullet("Threatened preterm labour at 24–34 weeks of gestation") bullet("Elective C-section before 37 weeks") bullet("Optimal benefit: If delivered 24 hours to 7 days after first dose") h3("Benefits") bullet("Reduces RDS incidence by ~50%") bullet("Reduces IVH (intraventricular haemorrhage)") bullet("Reduces NEC (necrotising enterocolitis)") bullet("Reduces neonatal mortality") bullet("Promotes lung maturation: Increases surfactant production + lung structural maturity") h3("Contraindications") bullet("Active maternal infection (chorioamnionitis — relative contraindication; weigh risk-benefit)") bullet("Maternal diabetes (causes transient hyperglycaemia — monitor closely)") bullet("Gestational age > 34 weeks (benefit not proven)") h2("Q19. Temperature Regulation in Neonates and Hypothermia") h3("Neonatal Thermoregulation") bullet("Neonates are POIKILOTHERMIC (limited ability to regulate temperature)") bullet("Mechanisms of heat loss: Evaporation (major at birth), Radiation, Conduction, Convection") bullet("Brown fat (BAT) thermogenesis — main heat-generating mechanism in neonates; absent in preterm") bullet("Neutral thermal environment (NTE): Temperature range where O2 consumption is minimum") add_table( ["Classification","Temperature","Action"], [ ["Normal","36.5–37.5°C","Routine care"], ["Mild Hypothermia (Cold stress)","36.0–36.4°C","Rewarm; kangaroo care; cover head"], ["Moderate Hypothermia","32.0–35.9°C","Warm in incubator; IV glucose; monitor"], ["Severe Hypothermia","< 32°C","Urgent rewarming; manage hypoglycaemia, acidosis; O2"], ] ) h3("Management of Severe Hypothermia") bullet("Warm slowly (0.5–1°C/hr) to avoid hypoglycaemia, apnoea and cardiovascular instability") bullet("Kangaroo Mother Care (KMC): Skin-to-skin contact — most effective for mild-moderate") bullet("Radiant warmer or incubator for severe hypothermia") bullet("IV dextrose 10% for hypoglycaemia") bullet("Monitor: Temperature every 15–30 min; blood glucose, ABG") h2("Q22 & Q23. ARDS / Hyaline Membrane Disease (see also Q14)") body("ARDS in children = Acute Respiratory Distress Syndrome (paediatric ARDS — pARDS)") add_table( ["Feature","Hyaline Membrane Disease (HMD/RDS)","pARDS"], [ ["Population","Preterm neonates","Any age child (usually > 1 month)"], ["Primary cause","Surfactant deficiency","Systemic inflammatory response → capillary leak"], ["Common triggers","Prematurity","Sepsis, pneumonia, aspiration, near-drowning"], ["X-ray","Ground glass opacity + air bronchograms","Bilateral infiltrates"], ["Key treatment","Surfactant replacement + CPAP","Lung-protective ventilation (low tidal volume 6 mL/kg)"], ] ) pagebreak() print("Topics 5-6 written successfully") doc.save("/tmp/workspace/pediatrics-answerbook/part1.docx") PYEOF
???